Connect with us

Technology

Neurophet to launch total solution for AD treatments ‘Neurophet AQUA AD’ at AAIC 2024

Published

on

– Demonstrates Neurophet AQUA AD for AD treatments such as Leqembi and Kisunla

– Introduces updated version of Neurophet SCALE PET with centiloid scale feature

SEOUL, South Korea, July 25, 2024 /PRNewswire/ — Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its participation in the Alzheimer’s Association International Conference (AAIC 2024) which will be held in Philadelphia, U.S.A.

At the upcoming AAIC, Neurophet will launch ‘Neurophet AQUA AD’, the software for Alzheimer’s disease (AD) treatment prescription and monitoring treatment effects and side effects. Neurophet AQUA AD is an integrated solution of cutting-edge brain image analysis technology related to AD treatments. This solution is currently preparing for medical device certifications in Korea, the U.S., and Japan.

Neurophet will offer demonstrations of Neurophet AQUA AD and showcase brain PET image analysis software ‘Neurophet SCALE PET’ with the major features updated at the company’s booth.

The AD treatment market is set to grow in earnest with this month’s FDA approval of Eli Lilly’s newest AD treatment Kisunla (donanemab) following Leqembi (lecanemab) which was developed by global pharmaceutical companies Eisai in Japan and Biogen in the U.S.

Anti-amyloid treatments like Kisunla and Leqembi bear a warning on the risk of amyloid-related imaging abnormalities (ARIA), which are known as side effects showing edema and microhemorrhages. In fact, ARIA has been reported in 20-30% of patients participating in clinical trials of both treatments. Patients undergoing anti-amyloid treatments are required to scan MRI at least 5~6 times a year for monitoring ARIA.

Neurophet AQUA AD is a software providing all the brain imaging biomarker analysis features required during the administration of anti-amyloid treatments, by quantitatively analyzing MRI and PET images. It is possible to determine the patients’ eligibility to prescribe the treatment before administration, monitor ARIA during administration, and analyze the effects of the treatment due to the reduction of amyloid beta deposited in the brain.

In addition, Neurophet will introduce a significantly updated version of Neurophet SCALE PET with centiloid scale feature. The centiloid scale quantitatively determines the positivity and negativity of amyloid PET images and standardizes amyloid plaque deposition from 1 to 100 in amyloid PET even when different tracers are used.

“We are excited to unveil our groundbreaking total solution for AD treatments at AAIC which is the global conference gathering scholars all over the world,” said CEO Jake Junkil Been of Neurophet. “We expect the use of Neurophet AQUA AD, a specialized technology for brain image analysis related to AD treatments, to be extremely high.”

The AAIC is the world’s largest conference for the advancement of dementia research, bringing dementia researchers, clinicians, and professionals together to share research and clinical practice on diagnosis, risk reduction, and treatment improvement of AD and other types of dementia. AAIC takes place in Philadelphia, U.S.A. this year, which starts on July 28th (local time) and runs until August 1st.

About Neurophet

Neurophet has specialized in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain diseases based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Jake Junkil Been, CEO, and Donghyeon Kim, CTO, who developed the next-generation neuro-navigation system.

Major products include brain MRI analysis software “Neurophet AQUA”, brain PET image analysis (PET tracer deposition) software “Neurophet SCALE PET”, brain imaging treatment planning software for electric and magnetic brain stimulation “Neurophet tES/TMS LAB”.

Neurophet has set its top priority to helping patients suffering from brain diseases. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain’s health and pioneer solutions for brain diseases with AI technology.

View original content to download multimedia:https://www.prnewswire.com/news-releases/neurophet-to-launch-total-solution-for-ad-treatments-neurophet-aqua-ad-at-aaic-2024-302204882.html

SOURCE Neurophet

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Equifax Announces Participation in Upcoming Investor Conferences

Published

on

By

ATLANTA, May 1, 2026 /PRNewswire/ — Equifax® (NYSE: EFX) will participate in several upcoming investor conferences in May and June.

Mark W. Begor, Chief Executive Officer, and John Gamble, Chief Financial Officer, will participate in the Baird 2026 Global Consumer, Technology & Services Conference on Tuesday, June 2, 2026 including participation in a Fireside Chat at 10:50 a.m., Eastern Time and the William Blair 2026 Growth Stock Conference on Wednesday, June 3, 2026, including participation in a Fireside Chat at 9:40 a.m., Eastern Time. 

The company invites investors to join a live webcast of these Fireside Chat events at: https://investor.equifax.com/news-events/ir-calendar. A replay of these Fireside Chats will be available within 24 hours after the event on the company’s Investor Relations website. 

John Gamble, Chief Financial Officer, will attend the Bernstein Annual Strategic Decisions Conference on Wednesday, May 27, 2026. 

Trevor Burns, Senior Vice President of Corporate Investor Relations, will attend the Barclays Americas Select Franchise Conference on Tuesday, May 5, 2026, the virtual Needham Technology, Media, & Consumer Conference on Thursday, May 14, 2026, and the J.P. Morgan All Stars Canada Conference on Tuesday, June 2, 2026.

ABOUT EQUIFAX INC.
At Equifax (NYSE: EFX), we believe knowledge drives progress. As a global data, analytics, and technology company, we play an essential role in the global economy by helping financial institutions, companies, employers, and government agencies make critical decisions with greater confidence. Our unique blend of differentiated data, analytics, and cloud technology drives insights to power decisions to move people forward. Headquartered in Atlanta and supported by nearly 15,000 employees worldwide, Equifax operates or has investments in 24 countries in North America, Central and South America, Europe, and the Asia Pacific region. For more information, visit Equifax.com.

FOR MORE INFORMATION:
Molly Clegg for Equifax
mediainquiries@equifax.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/equifax-announces-participation-in-upcoming-investor-conferences-302760292.html

SOURCE Equifax Inc.

Continue Reading

Technology

Cisco Schedules Conference Call for Q3 Fiscal Year 2026 Financial Results

Published

on

By

SAN JOSE, Calif., May 1, 2026 /PRNewswire/ — Cisco (NASDAQ: CSCO) has scheduled a conference call for Wednesday, May 13, 2026, at 1:30 PM (PT); 4:30 PM (ET) to announce its third quarter fiscal year 2026 financial results for the period ending Saturday, April 25, 2026.

Financial results will be released over PR Newswire via US National and European Financial distribution, after the close of the market on Wednesday, May 13, 2026. Cisco’s quarterly earnings press release will be posted at https://newsroom.cisco.com.

Date:
Wednesday, May 13, 2026

Time:
1:30 PM (PT); 4:30 PM (ET)

To Listen via Telephone: 
888-848-6507
212-519-0847 (for International Callers)

To Listen via the Internet: 
We are pleased to offer a live and replay audio broadcast of the conference call with corresponding slides at https://investor.cisco.com.

The conference call will also be livestreamed on YouTube & LinkedIn.

Replay:
A telephone playback of the Q3 FY2026 conference call is scheduled to be available beginning at 4:00 PM (PT) on May 13, 2026, through 10:00 PM (PT) May 19, 2026. The replay will be accessible by calling 800-839-2232 (International callers: 203-369-3662). The call runs 24 hours/day, including weekends. An archived version of the webcast will be available on Cisco’s Investor Relations website at https://investor.cisco.com.

About Cisco

Cisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has securely connected the world. With its industry leading AI-powered solutions and services, Cisco enables its customers, partners and communities to unlock innovation, enhance productivity and strengthen digital resilience. With purpose at its core, Cisco remains committed to creating a more connected and inclusive future for all. Discover more on The Newsroom and follow us on X at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco’s trademarks can be found at http://www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word ‘partner’ does not imply a partnership relationship between Cisco and any other company.

Investor Relations Contact: 

Press Contact: 

Sami Badri

Britt Stagnaro

Cisco

Cisco

sambadri@cisco.com

media_pr@external.cisco.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cisco-schedules-conference-call-for-q3-fiscal-year-2026-financial-results-302760253.html

SOURCE Cisco Systems, Inc.

Continue Reading

Technology

Essen Health Care Launches RADIN Health All-In-One RIS and PACS Cloud Platform

Published

on

By

SHERIDAN, Wyo.  , May 1, 2026 /PRNewswire/ — Essen Health Care is thrilled to announce a significant advancement in our commitment to providing exceptional patient care and cutting-edge medical services: the introduction of RADIN Health.

This initiative represents a major investment in the future of medical imaging, solidifying our dedication to offering the highest quality diagnostic services and an unparalleled patient and provider experience within the communities we serve.

“RADIN Health is more than just a technology upgrade; it is a fundamental pillar of Essen Health Care’s strategy to deliver accessible, efficient, and superior diagnostic imaging services to our community”, says Jonathan Khodadadian, MD, Medical Director, Specialty Division, Essen Health Care.  

The RADIN Platform: A Commitment to Innovation

RADIN Health is powered by an advanced, end-to-end, all-in-one RIS and PACS radiology cloud platform. This state-of-the-art system has been meticulously designed to revolutionize the imaging process, ensuring efficiency, accuracy, and accessibility for everyone involved.

Transforming the Patient and Provider Journey

The RADIN platform utilizes sophisticated, state-of-the-art artificial intelligence (AI) across multiple facets of the imaging journey:

Enhanced Patient and Provider Engagement: AI tools, patient, and referring physician portals streamline orders for appointments and communication, ensuring the external workflow process is easy, transparent, and accessible.Easy Image and Report Sharing: The cloud application allows easy electronic sharing and access of images and reports for providers and patients.Ease of Scheduling: The system simplifies the typically complex scheduling process, allowing for quick, convenient, and accurate appointment booking.Optimized Physician Reporting: AI assists in the generation of detailed, rapid, and precise physician reports, ensuring healthcare providers receive the critical information they need promptly to guide treatment decisions.

Driving Efficiency and Quality

The RADIN platform elevates the operational standards of imaging services. By reducing manual steps throughout the process—from order entry to image archival—and improving overall system efficiency, the platform ensures:

Timely Imaging Services: Quicker turnaround times mean patients receive their diagnoses faster, enabling earlier treatment planning.High-Quality Diagnostics: The system supports consistent, high-fidelity imaging quality, leading to more accurate diagnoses.Patient Follow-up Tracking: Recommended patient follow-up scans are automated and track recommendations for important, abnormal or inconclusive findings.Compliance and Best Practices: The cloud platform is built to support stringent regulatory compliance and adherence to the highest industry standards and best practices, giving both providers and patients confidence in the care received.

Essen Health Care is an integrated, multi-specialty healthcare delivery organization with more than 25 years of experience providing quality, compassionate, and accessible medical care to communities across New York. Offering house calls, urgent care, primary care, and specialty services, Essen Health Care is committed to advancing health equity and improving health outcomes for all patients. For more information, visit https://www.essenhealthcare.com

RADIN HealthⓇ is focused on developing SaaS products that enhance the efficiency, productivity, and scalability of hospitals, imaging centers and radiology practices. Utilizing artificial intelligence (AI), machine learning (ML), and natural language processing (NLP), Radin Health offers a Cloud-based, Serverless, All-In-One RIS, PACS, Dictation AI®, and Select® Workflow Management Solution. For more information, visit www.radinhealth.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/essen-health-care-launches-radin-health-all-in-one-ris-and-pacs-cloud-platform-302760463.html

SOURCE Radin LLC

Continue Reading

Trending